Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2019-04-05 10:51 (1871 d 02:29 ago) – Posting: # 20126
Views: 3,279

Hello to you too, PKS,

❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


What does your protocol say on exactly that matter?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
29 visitors (0 registered, 29 guests [including 5 identified bots]).
Forum time: 13:21 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5